What drove the significant increase in net earnings attributable to UnitedHealth Group common shareholders compared to the prior year?

The substantial increase in net earnings attributable to UnitedHealth Group common shareholders, from a loss of $1.4 billion in Q1 2024 to earnings of $6.3 billion in Q1 2025, was primarily driven by the absence of a significant loss of $7.1 billion related to the sale of a subsidiary in the prior year's comparative period. This allows the current period's strong operational performance to be clearly reflected in the bottom line.

How is the company managing rising medical costs, particularly in Medicare Advantage?

UnitedHealth Group is addressing rising medical costs through a multi-pronged approach. This includes managing medical and operating costs, adjusting care provider networks, modifying member benefits, and optimizing Medicare Advantage plan offerings on a county-by-county basis. The company is also working to mitigate increases by engaging with providers and consumers to promote high-quality, affordable care. However, the filing notes continued pressure from Medicare Advantage funding reductions and elevated care patterns for seniors.

What is the impact of the Inflation Reduction Act (IRA) on UnitedHealth Group?

The Inflation Reduction Act has altered the Medicare Part D model, shifting more risk to plans, which results in increased premiums and medical costs. It has also changed the seasonal progression of medical costs relative to premiums, leading to a more consistent relationship throughout the year. While this has created some adjustments, the company is working to mitigate these impacts.

What is the company's outlook regarding pending acquisitions?

As of March 31, 2025, UnitedHealth Group has entered into agreements to acquire companies in the health care sector, subject to regulatory approval. The total anticipated capital required for these acquisitions, excluding acquired debt, is approximately $4 billion, indicating continued strategic growth initiatives.

UNH 10-Q Quarterly Report Q1 FY2025 — Revenue, Net Income, EPS

Summary

UnitedHealth Group reported strong first-quarter 2025 results, demonstrating significant revenue growth and improved profitability. Total revenues increased by 10% year-over-year, driven by robust performance in its UnitedHealthcare and Optum segments. The company successfully managed medical costs, with the medical care ratio improving slightly, indicating effective cost control measures despite increased care patterns. Earnings from operations saw a substantial increase of 15%, reflecting operational efficiencies and recovery from the prior year's cyberattack impact. The company also highlighted growth in the number of people served, particularly in Medicare Advantage and commercial offerings, underscoring its market leadership. UnitedHealth Group maintained a healthy cash flow from operations, providing ample liquidity for its ongoing operations, strategic investments, and capital return programs, including share repurchases and dividends. The company's strong financial position and operational execution position it well for continued growth.

Financial Highlights

54 data points

Beta

Revenue

$109.58B

0.9% Gross Margin

Net Income

$6.29B

0.1% Net Margin

EPS (Diluted)

$6.85

Total Assets

$309.79B

Cash & Equivalents

$30.72B

Free Cash Flow

$4.56B

Financial Statements

Beta

Revenue	$109.58B
Cost of Revenue	$12.39B
Gross Profit	$97.19B
SG&A Expenses	$13.59B
Operating Expenses	$100.46B
Operating Income	$9.12B
Interest Expense	$998.00M
Net Income	$6.29B
EPS (Basic)	$6.90
EPS (Diluted)	$6.85
Shares Outstanding (Basic)	912.00M
Shares Outstanding (Diluted)	918.00M

Key Highlights

1Total revenues increased by 10% to $109.6 billion, driven by a 12% rise in UnitedHealthcare revenues and a 5% increase in Optum revenues.
2Earnings from operations grew by 15% to $9.1 billion, a significant improvement over the prior year, partly due to the absence of the prior year's cyberattack impact.
3UnitedHealthcare served 945,000 more people, with notable growth in Medicare Advantage and commercial offerings.
4The medical care ratio improved slightly to 84.8% from 84.3% in the prior year, indicating effective medical cost management.
5Cash flow from operations was robust at $5.5 billion for the quarter, demonstrating strong operational cash generation.
6The company repurchased $3.0 billion of common stock and paid $1.9 billion in dividends, demonstrating a commitment to returning capital to shareholders.
7Optum Rx revenues increased by 14% and Optum Insight revenues grew by 3%, showcasing strength in these key Optum sub-segments.

UNITEDHEALTH GROUP INC Quarterly Report for Q1 Ended Mar 31, 2025

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions